Larvol Delta - Regulus-Therapeutics-Announces-FDA-Orphan-Drug-Designation-of-RGLS4326-for-the-Treatment-of-Autosomal-Dominant-Polycystic-Kidney-Disease-ADPKD--

RGLS4326 - Regulus Therapeutics

prnewswire.com/news-releases/regulus-therapeutics-announces-fda-orphan-drug-designation-of-rgls4326-for-the-treatment-of-autosomal-dominant-polycystic-kidney-disease-adpkd-301101933.html

Jul 29, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next